ALSO READShilpa Medicare gains on bargain hunting Shilpa Medicare gains after raising funds Shilpa Medicare gains after USFDA approval for Azacitidine injection Shilpa Medicare gains after board's nod to raise foreign investment limit Themis Medicare standalone net profit rises 52.04% in the September 2016 quarter
Meanwhile, the S&P BSE Sensex was down 83.70 points, or 0.28% to 29,435.04.
On the BSE, 7,127 shares were traded in the counter so far, compared with average daily volumes of 1,866 shares in the past one quarter. The stock had hit a high of Rs 598 and a low of Rs 583.20 so far during the day. The stock hit a record high of Rs 708.95 on 28 October 2016. The stock hit a 52-week low of Rs 325 on 29 March 2016.
The stock had underperformed the market over the past one month till 20 March 2017, rising 1.16% compared with 3.69% rise in the Sensex. The scrip had also underperformed the market in past one quarter, rising 1.33% as against Sensex's 12.20% rise.
The small-cap company has equity capital of Rs 9.04 crore. Face value per share is Rs 10.
On a consolidated basis, Themis Medicare's net profit fell 25.37% to Rs 3.56 crore on 12.48% increase in net sales to Rs 62.11 crore in Q3 December 2016 over Q3 December 2015.
Themis Medicare is a pharmaceutical company, engaged in manufacturing pharmaceuticals and medicinal chemicals.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)